BU-NOT-SET

CONTACT US
Recipharm launches new virtual inspection and audit tool for customers, in light of COVID-19 outbreak
  • Manufacturing
Eyes
Insight
Recipharm 25 years
  • Corporate
24 years
Brochure
API product list
  • Drug substance
white pills
Fact sheet
Inhibition of 19S proteasome deubiquitinating activity in Schistosoma mansoni affects viability, oviposition, and structural changes
  • Drug substance
Eyes
Insight
The demand for antibiotics and its impact on the pharmaceutical industry since the outbreak of COVID-19
  • Industry trends
Eyes
Insight
Women in leadership
  • Corporate
Eyes
Insight
The state of the oral solid dose development and manufacturing market
  • Drug product
Eyes
Insight
Characterising APIs is Essential for Combo Drug Formulations
  • Drug substance
Eyes
Insight
Outsourcing stability testing
  • Analytical chemistry
Eyes
Insight
Insight
  • Biologics
Regulatory challenges in gene therapy manufacturing
Webinar
  • Drug product
Reformulation strategies to enhance and extend your drug product success
Insight
  • Biologics
Gene therapy manufacturing journey
Insight
  • Biologics
Pushing boundaries in mRNA vaccine manufacturing
Fact sheet
  • Analytical chemistry
Nitrosamines analysis
Insight
  • Biologics
  • Drug substance
Enabling oral solid dosage form delivery of biologics
Fact sheet
  • Biologics
Plasmid DNA manufacturing capabilities
Insight
  • Analytical chemistry
  • Drug substance
Leveraging analytics throughout development and manufacture to achieve commercial success
Insight
  • Sustainability
2,300 solar panels installed at Recipharm’s Holmes Chapel